Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
HAEHaemonetics(HAE) Zacks Investment Research·2024-05-10 23:56

Haemonetics Corporation (HAE) delivered adjusted earnings per share (EPS) of 90 cents for the fourth quarter of fiscal 2024, up 16.9% year over year. The bottom line surpassed the Zacks Consensus Estimate by 2.3%. On a GAAP basis, EPS was 40 cents, down 29.8% from the prior-year quarter’s levels. For the full year, adjusted earnings were 3.96pershare,up30.73.96 per share, up 30.7% from the year-ago period’s figure. It beats the Zacks Consensus Estimate by 03%. Total Revenues Revenues increased 12.8% to 343.3 million in the ...